28 April 2021 - Thousands of people with high cholesterol will soon have access to a new treatment option on the NHS as a result of final NICE guidance published today.
Around 70,000 adults in England with primary hypercholesterolaemia or mixed dyslipidaemia, also known as high cholesterol, will now be eligible for treatment with bempedoic acid with ezetimibe, if statins cannot be taken, or have not worked for them.